SCHEMBL29529970

SCHEMBL29529970

NCc1ccncc1OCc1ncccc1F

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 1/20 0.49
AOC1 P19801 7/20 0.39
AOC3 Q16853 7/20 0.39
SGMS2 Q8NHU3 2/20 0.36
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
HDAC1 Q13547 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HTR1A P08908 1/20 0.33
DRD2 P14416 1/20 0.33
DPP4 P27487 1/20 0.33
MAOB P27338 1/20 0.33
PDE4A P27815 1/20 0.32
GPR84 Q9NQS5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25321326 1.00 LOXL2 (0.49) LOXL2AOC1AOC3SGMS2ALOX5AP
SCHEMBL25319948 0.83 SGMS2 (0.39) LOXL2AOC1AOC3SGMS2MAOB
SCHEMBL29530172 0.77 FEN1 (0.47) SGMS2ALOX5APFEN1
SCHEMBL25320280 0.77 FEN1 (0.47) SGMS2ALOX5APFEN1
SCHEMBL29102392 0.77 SGMS2 (0.35) AOC1AOC3SGMS2HDAC1HDAC6
SCHEMBL29102375 0.76 KDM4C (0.45) SGMS2MEN1KMT2A
SCHEMBL17962510 0.75 AOC3 (0.55) LOXL2AOC1AOC3SGMS2HTR1A
SCHEMBL25321760 0.74 LOXL2 (0.44) LOXL2AOC1AOC3MEN1KMT2A
SCHEMBL29530331 0.74 LOXL2 (0.44) LOXL2AOC1AOC3MEN1KMT2A
SCHEMBL25320177 0.73 AOC3 (0.40) LOXL2AOC1AOC3ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4217070-A1 PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER Scorpion Therapeutics, Inc. (US) 2023-08-02 EP disclosed
WO-2022066734-A1 PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER SCORPION THERAPEUTICS, INC. (US) 2022-03-31 WO disclosed